🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study aims to evaluate the safety and immunogenicity of the 10-valent a...
Status
Unknown
Location
Papua New Guinea Institute of Medical Research
Start Date
2011-11
Trial ID
NCT01619462
Treatments Being Tested
The purpose of this study is to determine whether an early schedule of a co...
Status
Completed
Location
Menzies School of Health Research
Start Date
2011-08
Trial ID
NCT01174849
Treatments Being Tested
The National Vaccine Evaluation Consortium conducts Department of Health fu...
Status
Withdrawn
Location
Hertfordshire primary care
Start Date
TBD
Trial ID
NCT02918708
Treatments Being Tested
This study will assess the safety, reactogenicity and immunogenicity of two...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-09-27
Trial ID
NCT01204658
The goal of the research proposed in the current application is to first de...
Status
Terminated
Location
Ralph H. Johnson VA Medical Center, Charleston, SC
Start Date
2018-11-01
Trial ID
NCT03802994
The purpose of this observational study is to examine the risk of adverse e...
Status
Unknown
Location
Sungkyunkwan University
Start Date
2021-08-01
Trial ID
NCT04551248
HYPOTHESES: 1. That infants receiving PHiD-CV10 as a booster at 12 months ...
Status
Completed
Location
Menzies School of Health Research
Start Date
2013-03-12
Trial ID
NCT01735084
Treatments Being Tested
The primary aim of this study is to assess the reactogenicity of Synflorix ...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-09-04
Trial ID
NCT01641133
This Phase III, open-label, randomized, parallel-group, active-controlled, ...
Status
Completed
Location
Multiple Locations
Start Date
2016-11-07
Trial ID
NCT03205371
Treatments Being Tested